FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

LUPIN Share Price Discussion

Lupin Ltd.
Sector: Pharmaceuticals and health care
... Read more

Find answers to all your questions on live LUPIN message board: Is LUPIN buy or sell? Should I buy LUPIN shares? Why are LUPIN shares falling? Should I invest in LUPIN stock?


You can also check LUPIN share price target recommended by brokerages.

@100billionclub • Reputation: 3,804

FNO: BUY LUPIN ABV 774
Like
reply
Reply
Recent posts in LUPIN

💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
SELL LUPIN AT THE VERY BEGINING
STRICT STOP LOSS - 775
1ST TARGET - 759
2ND TARGET - 755
3RD TARGET - 750
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult w...
Read more...
Like
reply
Reply
@ansarshaikh • Reputation: 48

Positional buy call sl 740 tgt 818
Like
reply
Reply
@stocktrendr • Reputation: 127

Lupin received five observations from the US health regulator after inspection of its Vizag facility in Andhra Pradesh. The inspection of company's Vizag API manufacturing facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in a filin...
Read more...
Like
reply
Reply
@invictotrader • Reputation: 2,053

Lupin gets 5 observations from USFDA for its Vizag facility The inspection was carried out between January 13, 2020 and January 17, 2020, it added.
Like
reply
Reply
@nishantshah91 • Reputation: 3,251
LUPIN

Type
Buy
Instrument
LUPIN
Entry Price
₹769
Price@Trade
₹768.55
Target Price
₹800
Stop Price
₹749
Valid Till
Feb 17, 2020 3:20 PM
Margin
₹769 approx for 1 Qty
Status
Stoploss Hit
Net P&L
-2.6% Loss
Buy Cmp and in dips till 760
Like
reply
Reply (2)
@rajivkumarjha • Reputation: 12,982
LUPIN JAN20 760 CE

Type
Buy
Instrument
LUPIN JAN20 760 CE
Entry Price
₹15.3
Price@Trade
₹15.3
Target Price
₹40
Stop Price
₹3
Valid Till
Jan 30, 2020 3:20 PM
Margin
₹10,710 approx for 700 Qty
Status
Exited
Exit Price
₹17.7
Net P&L
15.69% Profit
Like
reply
Reply (1)